Vaccination for Recovered Inpatients with COVID-19 (VATICO) - Clinical Trial

What is the Purpose of this Study?

This study is looking at how the immune system responds to one type of COVID-19 vaccine called an mRNA vaccine.

What is the Condition Being Studied?

COVID-19

Who Can Participate in the Study?

Adults who participated in the ACTIV-3/TICO research study and have not received a vaccine for COVID-19.

Age Group
Adults

What is Involved?

If you choose to join this study, you will:
- Receive a vaccine for COVID-19
- Be assigned to one of 4 groups to determine when you will receive your vaccine and if you will get one or two doses
- Have blood draws
- Have your medical information collected

Study Details

Full Title
SARS-CoV-2 vaccination strategies in previously hospitalized and recovered COVID-19 patients
Principal Investigator
Heart Surgeon
Protocol Number
IRB: PRO00108774
Phase
Phase III
Enrollment Status
Open for Enrollment
Participate
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698